FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/083096 [Registered on: 21/03/2025] Trial Registered Prospectively
Last Modified On: 20/03/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Medical Device
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Rhomboid Intercostal and Subserratus plane block in patients with multiple rib fracture for pain management  
Scientific Title of Study   Analgesic efficacy of Rhomboid Intercostal and Subserratus plane block in patients with multiple rib fracture:A randomised controlled trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Rekha Kumari 
Designation  Assistant professor 
Affiliation  AIIMS PATNA 
Address  Department of Trauma Surgery and Critical Care Aiims patna

Patna
BIHAR
801507
India 
Phone  7903481143  
Fax    
Email  dr.rekha11636@aiimspatna.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Rekha Kumari 
Designation  Assistant professor 
Affiliation  AIIMS PATNA 
Address  Department of Trauma Surgery and Critical Care Aiims patna

Patna
BIHAR
801507
India 
Phone  7903481143  
Fax    
Email  dr.rekha11636@aiimspatna.org  
 
Details of Contact Person
Public Query
 
Name  Dr Rekha Kumari 
Designation  Assistant professor 
Affiliation  AIIMS PATNA 
Address  Department of Trauma Surgery and Critical Care Aiims patna

Patna
BIHAR
801507
India 
Phone  7903481143  
Fax    
Email  dr.rekha11636@aiimspatna.org  
 
Source of Monetary or Material Support  
Department of Trauma Surgery and Critical Care AIIMS Patna Phwarisharif, India, Pin code-801507 
 
Primary Sponsor  
Name  All India Institute of medical Sciences Patna 
Address  Department of trauma surgery and critical care AIIMS Patna, Phulwarisharif, PIN code-801507 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NA  NA 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Rekha Kumari  All India Institute of Medical sciences,Patna  Department of trauma surgery and Critical Care, Trauma Building, 3rd floor OT complex OT No-2
Patna
BIHAR 
7903481143

dr.rekha11636@aiimspatna.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC AIIMS PATNA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J951||Acute pulmonary insufficiency following thoracic surgery, (2) ICD-10 Condition: J709||Respiratory conditions due to unspecified external agent,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Group 1 will receive IV patient controlled analgesia with RISS block   USG guided RISS block with 20 ml of0.25%bupivacaine will be given. and Intravenous PCA pump (2mg morphine bolus dose) Total duration :48 hour  
Comparator Agent  Group 2: will receive only Patient controlled analgesia  IV PCA Morphine 2 mg Bolus dose with 15 min lock out interval Total duration : 48 hour 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Rib fracture that induced any respiratory symptoms
History of Trauma not older than one week with multiple, unilateral, or bilateral rib fractures  
 
ExclusionCriteria 
Details  long-standing analgesic therapy
opioids dependence
communication difficulty and any bleeding disorder
hemodynamically unstable
intubated patients
polytrauma 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
TO measure the total morphine consumption in 48 hrs

 
48 hour  
 
Secondary Outcome  
Outcome  TimePoints 
Time of first rescue analgesia
Hemodyanamic parameter

Adverse effect  
NRS at 30 min,2 hr,4hr,8hr,12hr,then every 6hr until 48hr 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   21/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The RISS block may be a good addition to 
pain control management in multiple Rib fractures as part of multimodal analgesia.
It reduces opioid consumption and more Pain relief.
RISS block has fewer adverse effects than IV PCA.
 
Close